IN THE NEWS

<< Back to List
October 12, 2011

Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors

Oncobiologics, Inc. announced today that is has named Scott Canute, a former President at both Eli Lilly and Genzyme, to its Board of Directors.

Over the course of his 30-year career, Mr. Canute played a vital role in leading Eli Lilly's global manufacturing operations. Most recently, he spent more than a year as President of Global Manufacturing and Corporate Operations for Genzyme, where he led a major turnaround effort.

"Scott Canute has been a distinguished leader at major biopharmaceutical organizations throughout his career," said Oncobiologics Founder & CEO Pankaj Mohan, Ph.D. "I have known and admired Scott as my mentor for many years, and I am honored that he will share his experience and strategic insight to our efforts at Oncobiologics. We look forward to guidance from Scott as a member of our board."

"Oncobiologics has assembled an impressive team of industry leaders, and already has developed a promising pipeline," said Mr. Canute. "Although the company is a start-up, it has the horsepower of a much more established organization. I look forward to helping Pankaj steer the company through this exciting stage."

Mr. Canute earned a Master of Business Administration from the Harvard Business School. He also earned a B.S. in Chemical Engineering at the University of Michigan, where he graduated with Highest Honors.